Albert David Limited
Incorporated in 1938, Albert DavidLtd is in the business of manufacturing pharmaceutical products
What Albert files
- Others76
- Board Meeting14
- Important10
- Results6
- Updates5
- Dividend/Bonus4
Albert David appointed Amit Mahla as CEO. The company reported a Q4 net loss of ₹21.43 Cr and a full-year net loss of ₹1.49 Cr. A final dividend of ₹5 per share was proposed. The AGM is scheduled.
Albert David has announced a board meeting to consider the financial results for the quarter and half-year. The company is initiating transfer of unclaimed dividends and corresponding shares from FY 2017-18 onwards to the Investor Education and Protection Fund (IEPF) as per applicable rules. Shareholders holding unclaimed dividends are urged...
Albert David Ltd has dispatched KYC update requests to all physical shareholders (373 in total) to ensure compliance with PAN, KYC, nomination, and bank details requirements. Shareholders must submit completed KYC forms via the company's or registrar’s website to continue receiving dividends. Non-compliance will result in withholding dividend payments. No...
Albert David Limited has announced a board meeting on May 13, 2025, approving audited financial results for the quarter and financial year ended March 31, 2025, with a clean audit report. The board proposed a final dividend of Rs. 5 per share (50%), pending shareholder approval. PricewaterhouseCoopers LLP and S....
Albert David has announced a board meeting to approve the financial results for the quarter and half-year. The company proposed a final dividend of Rs. 5 per share (50%), pending shareholder approval. PricewaterhouseCoopers and S. Gupta & Co. were reappointed as Internal and Cost Auditors, respectively, while M/s. MKB &...